Weight Loss: The Data At this time, there arent any published head-to-head obesity trials directly comparing oral semaglutide to orforglipron, says Maria Teresa Anton, MD, a board-certified internal medicine physician who specializes in endocrinology, diabetes, and metabolism with Pritikin Longevity Center in Miami
The 12 mg weekly dose problem: when 30 mg vials get awkward A patient titrated to the upper Phase 2 retatrutide dose (12 mg weekly) and using a 30 mg vial faces a constraint: the dose volume needs to stay inside one U-100 syringe
Below is a simple guide to what tapering usually looks like
Patients are increasingly curious about glutathionewhy not offer them a product that has been scrutinized at the highest scientific levels
What are the pros and cons of GLP-1 weight loss drugs
These tiny, double-membraned Read Articles